FDA Approves Donanemab, Eli Lilly’s New Drug for Early Alzheimer’s

The drug, Kisunla, made by Eli Lilly, is the latest in a new class of treatments that could modestly slow cognitive decline in initial stages of the disease but also carry safety risks.

  General   Jul 2, 2024   0   59  Add to Reading List
FDA Approves Donanemab, Eli Lilly’s New Drug for Early Alzheimer’s






The drug, Kisunla, made by Eli Lilly, is the latest in a new class of treatments that could modestly slow cognitive decline in initial stages of the disease but also carry safety risks.
Read Original   

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow